Stephens & Co. Reiterates Overweight on Itron, Maintains $130 Price Target

Benzinga Newsdesk www.benzinga.com Neutral 57.7%

Neg 0% Neu 57.7% Pos 0%

Stephens & Co. analyst Tommy Moll reiterates Itron (NASDAQ:ITRI) with a Overweight and maintains $130 price target.

Comments

No comments yet. Be the first!

Stephens &amp; Co. Reiterates Overweight on Itron, Maintains $130 Price Target